- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 27/14 - Decongestants or antiallergics
Patent holdings for IPC class A61P 27/14
Total number of patents in this class: 323
10-year publication summary
|
8
|
11
|
18
|
12
|
12
|
20
|
16
|
8
|
10
|
9
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Santen Pharmaceutical Co., Ltd. | 601 |
16 |
| Daiichi Sankyo Company, Limited | 1875 |
10 |
| Dainippon Sumitomo Pharma Co., Ltd. | 181 |
8 |
| Senju Pharmaceutical Co., Ltd. | 228 |
7 |
| Glenmark Specialty S.A. | 77 |
6 |
| Taisho Pharmaceutical Co., Ltd. | 865 |
6 |
| AstraZeneca AB | 2877 |
5 |
| Alcon Research, Ltd. | 350 |
4 |
| Aldeyra Therapeutics, Inc. | 103 |
4 |
| Allakos Inc. | 60 |
4 |
| Bausch & Lomb Incorporated | 1105 |
4 |
| Industry-Academic Cooperation Foundation, Yonsei University | 2417 |
4 |
| Novartis AG | 10709 |
3 |
| Takeda Pharmaceutical Company Limited | 2706 |
3 |
| Ewha University-industry Collaboration Foundation | 737 |
3 |
| KYORIN Pharmaceutical Co., Ltd. | 166 |
3 |
| NTC S.r.l. | 78 |
3 |
| Ora, Inc. | 21 |
3 |
| Otsuka Pharmaceutical Co., Ltd. | 1496 |
3 |
| Shionogi & Co., Ltd. | 843 |
3 |
| Other owners | 221 |